At launch, Healthc’Air has secured two major clients, ECS Group and GLOBAL GSA, both well-known names in the industry.
A new name is making waves in the world of pharmaceutical air logistics. Healthc’Air, a recently launched company dedicated to improving the global handling of temperature-sensitive pharmaceutical shipments, promises to raise the bar for quality, innovation, and sustainability in the fast-evolving life sciences supply chain.
Led by Yulia Celetaria, Global Director Pharma and a seasoned expert in pharmaceutical logistics, Healthc’Air positions itself as a high-value partner for airlines and General Sales Agents (GSAs) looking to enhance their pharmaceutical cargo offerings.
“Our ambition at Healthc’Air is to go beyond current industry standards,” said Celetaria. “We aim to build, hand in hand with our clients, solutions that combine operational excellence, digital innovation, and sustainable commitment. By listening closely to real market needs and bringing together top experts, we will sustainably transform pharmaceutical air logistics.”
The company launches with early momentum, having secured two major industry clients: ECS Group and GLOBAL GSA. According to a company statement, Healthc’Air is also in advanced discussions with more than a dozen airlines globally, all seeking to either establish or enhance their pharma cargo capabilities.
Healthc’Air’s value proposition lies in its multi-tiered service model, which includes three customizable offerings—Launch, Advanced, and Trust—designed to provide varying levels of support based on each airline’s operational maturity and strategic goals. Services span a wide spectrum, from compliance consulting and certification support to shipment auditing, training, and the deployment of AI-powered digital tools for better performance tracking and risk management.
A strong emphasis on sustainability also sets Healthc’Air apart. The company is actively developing green logistics solutions aimed at reducing the environmental impact of pharmaceutical transportation—an increasingly important objective as the healthcare sector strives to decarbonize its supply chain.
The launch of Healthc’Air comes at a critical juncture for pharmaceutical air logistics. Post-pandemic demand for reliable, GDP-compliant cargo services remains high, driven by the global distribution of vaccines, biologics, and precision medicines. At the same time, the industry faces mounting pressure to digitize operations, minimize waste, and meet increasingly complex regulatory requirements.
With a leadership team steeped in industry knowledge and a client-centric approach focused on operational excellence and digital transformation, Healthc’Air is poised to play a defining role in the next chapter of pharmaceutical logistics.
As 2025 unfolds, the company plans to pilot and refine its service models based on real-time market feedback, ensuring its offerings remain closely aligned with the evolving needs of airlines, forwarders, and pharmaceutical manufacturers.
